CVRX
Price
$0.70Alerts
Change
-$0.00 (-0.00%)
Updated
Nov 11 closing price
Capitalization
23.14M
97 days until earnings call
Intraday BUY SELL Signals
NSPR
Price
$0.80Alerts
Change
+$0.03 (+3.90%)
Updated
Nov 11 closing price
Capitalization
32.6M
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

CVRX vs NSPR

CVRX vs NSPR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CVRX vs. NSPR commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVRX is a Buy and NSPR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CVRX with price predictions
Nov 11, 2026

CVRX in upward trend: price may jump up because it broke its lower Bollinger Band on November 06, 2026

CVRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 35 of 39 cases where CVRX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +15.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where CVRX advanced for three days, in 245 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CVRX as a result. In 64 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.

The Moving Average Convergence Divergence Histogram (MACD) for CVRX turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 36 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for CVRX entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.160) is normal, around the industry mean (4.142). P/E Ratio (-0.441) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.292) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. CVRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for NSPR with price predictions
Nov 11, 2026

NSPR in upward trend: 10-day moving average moved above 50-day moving average on November 11, 2026

The 10-day moving average for NSPR crossed bullishly above the 50-day moving average on November 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on NSPR as a result. In 83 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.

The Moving Average Convergence Divergence (MACD) for NSPR just turned positive on October 23, 2026. Looking at past instances where NSPR's MACD turned positive, the stock continued to rise in 40 of 50 cases over the following month. The odds of a continued upward trend are 80%.

NSPR moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +12.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where NSPR advanced for three days, in 152 of 201 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NSPR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

NSPR broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NSPR entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.035) is normal, around the industry mean (4.142). P/E Ratio (-1.141) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (5.767) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. NSPR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NSPR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
NSPR: Fundamental Ratings
NSPR
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
44
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVRXNSPR
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (CVRX: $0.70 vs. NSPR: $0.77)
Brand notoriety: CVRX and NSPR are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CVRX: 129% vs. NSPR: 156%
Market capitalization -- CVRX: $23.14M vs. NSPR: $32.6M
CVRX [@Medical/Nursing Services] is valued at $23.14M. NSPR’s [@Medical/Nursing Services] market capitalization is $32.6M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVRX’s FA Score shows that 1 FA rating(s) are green while NSPR’s FA Score has 0 green FA rating(s).

  • CVRX’s FA Score: 1 green, 4 red.
  • NSPR’s FA Score: 0 green, 5 red.
According to our system of comparison, NSPR is a better buy in the long-term than CVRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVRX’s TA Score shows that 4 TA indicator(s) are bullish while NSPR’s TA Score has 4 bullish TA indicator(s).

  • CVRX’s TA Score: 4 bullish, 4 bearish.
  • NSPR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CVRX is a better buy in the short-term than NSPR.

Price Growth

CVRX (@Medical/Nursing Services) experienced а -49.62% price change this week, while NSPR (@Medical/Nursing Services) price change was +17.60% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.

Reported Earning Dates

CVRX is expected to report earnings on Feb 17, 2027.

NSPR is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Medical/Nursing Services (-2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

CVRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVRX has been closely correlated with STRRP. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if CVRX jumps, then STRRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVRX
1D Price
Change %
CVRX100%
+0.70%
STRRP - CVRX
67%
Closely correlated
-1.10%
AZTA - CVRX
39%
Loosely correlated
+20.80%
IRTC - CVRX
36%
Loosely correlated
+3.04%
TMCI - CVRX
34%
Loosely correlated
+3.69%
A - CVRX
34%
Loosely correlated
-0.52%
More

NSPR and

Correlation & Price change

A.I.dvisor tells us that NSPR and LIVN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSPR and LIVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSPR
1D Price
Change %
NSPR100%
+3.40%
LIVN - NSPR
24%
Poorly correlated
-0.18%
MLSS - NSPR
23%
Poorly correlated
+6.10%
AVR - NSPR
23%
Poorly correlated
+5.26%
SNWV - NSPR
23%
Poorly correlated
-5.32%
CVRX - NSPR
23%
Poorly correlated
+0.70%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAUT2.420.10
+4.31%
Nautilus Biotechnolgy
NOV18.000.32
+1.81%
NOV
GSHD46.150.02
+0.04%
Goosehead Insurance
LOW231.60-0.27
-0.12%
Lowe's Companies
VAI2.27-0.20
-8.10%
Valor Energy Incorporated